TABLE 1.
Clinicopathological characteristics | Total cases | High NDUFS1 level | Low NDUFS1 level | Logit p | OR |
---|---|---|---|---|---|
Age | 0.894 | 1.091 | |||
<65 | 23 | 12 (60.0%) | 11 (57.9%) | ||
≥65 | 16 | 8 (40.0%) | 8 (42.1%) | ||
Sex | 0.434 | 1.671 | |||
Female | 16 | 7 (35.0%) | 9 (47.4%) | ||
Male | 23 | 13 (65.0%) | 10 (52.6%) | ||
Stage | 0.069 | 4.121 | |||
I+II | 28 | 17 (85.0%) | 11 (57.9%) | ||
III | 11 | 3 (15.0%) | 8 (42.1%) | ||
T stage | 0.641 | 1.429 | |||
T1+T2 | 30 | 16 (80.0%) | 14 (73.7%) | ||
T3+T4 | 9 | 4 (20.0%) | 5 (26.3%) | ||
N stage | 0.019* | 5.500 | |||
N0 | 24 | 16 (80.0%) | 8 (42.1%) | ||
N1+N2+N3 | 15 | 4 (20.0%) | 11 (57.9%) | ||
Differentiation | 0.039* | 0.225 | |||
Poorly | 14 | 4 (20.0%) | 10 (52.6%) | ||
Well/moderate | 25 | 16 (80.0%) | 9 (47.4%) | ||
ki67 | 0.152 | 2.571 | |||
<20 | 19 | 12 (60.0%) | 7 (36.8%) | ||
≥20 | 20 | 8 (40.0%) | 12 (63.2%) | ||
Tumor maximum diameter | 0.042* | 4.000 | |||
<3 cm | 21 | 14 (70.0%) | 7 (36.8%) | ||
≥3 cm | 18 | 6 (30.0%) | 12 (63.2%) | ||
Lymphatic and vascular invasion | 0.004** | 8.667 | |||
Negative | 22 | 16 (80.0%) | 6 (31.6%) | ||
Positive | 17 | 4 (20.0%) | 13 (68.4%) | ||
Nerve invasion | 0.261 | 2.182 | |||
Negative | 26 | 15 (75.0%) | 11 (57.9%) | ||
Positive | 13 | 5 (25.0%) | 8 (42.1%) |
p<0.05.
p<0.01.